Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Jul;48(1):37-42.
doi: 10.1046/j.1365-2125.1999.00948.x.

Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children

Affiliations
Clinical Trial

Morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children

R D Hain et al. Br J Clin Pharmacol. 1999 Jul.

Abstract

Aims: To measure morphine and morphine-6-glucuronide in the plasma and cerebrospinal fluid of children following a single intravenous dose of morphine.

Methods: Twenty-nine paired samples of cerebrospinal fluid and plasma were collected from children with leukaemia undergoing therapeutic lumbar puncture. An intravenous dose of morphine was administered at selected intervals before the procedure. Concentrations of morphine and morphine-6-glucuronide (M6G) were measured in each sample. Morphine was measured using a specific radioimmunoassay (r.i.a.) and M6G was measured using a novel enzyme-linked immunosorbent assay (ELISA).

Results: The ELISA for measuring M6G was highly sensitive. The intra-and interassay variations were less than 15%. Using a two-compartment model for plasma morphine, the area under the curve to infinity (AUC, 7143 ng ml-1 min), volume of distribution (3.6 l kg-1 ) and elimination half-life (88 min) were comparable with those reported in adults. Clearance (35 ml min-1 ) was higher than that in adults. Morphine-6-glucuronide was readily synthesized by the children in this study. The elimination half-life (321 min) and AUC (35507 ng ml-1 min) of plasma M6G were much greater than those of morphine.

Conclusions: Extensive metabolism of morphine to M6G in children with cancer has been demonstrated. These data provide further evidence to support the importance of M6G accumulation after multiple doses. There was no evidence that morphine passed more easily into the CSF of children than adults.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Concentration of morphine in plasma (ng ml−1) following administration of morphine to children with leukaemia. —predicted concentrations, ○ =observed concentrations.
Figure 2
Figure 2
Comparison of (a) morphine concentrations in plasma and CSF. (b) morphine-6-glucuronide concentrations in plasma and CSF. (c) morphine and M6G concentrations in plasma. (d) morphine and M6G concentrations in CSF. • =plasma morphine, ▾ =CSF morphine, ○ =plasma M6G, x =CSF M6G.

Similar articles

Cited by

References

    1. Shimomura K, Kamata O, Ueki S, Ida S, Oguri K. Analgesic effect of morphine glucuronides. Tohoku J Exp Med. 1971;105:45–52. - PubMed
    1. Pasternak GW, Bodnar RJ, Clark JA, Inturrisi CE. Morphine-6-glucuronide, a potent mu agonist. Life Sci. 1987;41:2845–2849. - PubMed
    1. Abbott FV, Palmour RM. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci. 1988;43:1685–1695. - PubMed
    1. Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6-beta glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989;251:477–483. - PubMed
    1. Gong QL, Hedner T, Hedner J, Bjorkman R, Nordberg G. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol. 1991;193:47–56. - PubMed

Publication types